Figure 3From: Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled studyKaplan-Meier estimates of probability of overall survival among patients with pulmonary atypical Mycobacteriosis treated with IFN gamma (solid line) or placebo (dashed line) adjuvant to chemotherapy.Back to article page